ILUZANEBART
UNII 23Q5AU2MD5

Substance Identification & Data

This profile provides standardized clinical and technical data for Iluzanebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23Q5AU2MD5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2733621-19-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

23Q5AU2MD5

CAS Registry Number

2733621-19-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ILUZANEBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199007

National Cancer Institute reference terminology for clinical and research data.

INN ID

12479

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-119

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Iluzanebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ILUZANEBART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-451) (VH (HOMO SAPIENS IGHV5-51*01 (96.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14, G1V54-30 CH2 C83, G84.4, C85 (CH1 R120>K (218) (122-219), HINGE 1-15 (220-234), CH2 R83>C (296), N84.4>G (301), V85>C(306) (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450- 451)) (122-451)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (94.7%)-IGKJ1*01 (90.9%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%) (108'-214')); DIMER (230- 230'':233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

ILUZANEBART [INN]

ILUZANEBART [USAN]

IMMUNOGLOBULIN G1 (296-CYSTEINE,301-GLYCINE,306-CYSTEINE), ANTI-(HUMAN TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2) (HUMAN MONOCLONAL VGL101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VGL101 .KAPPA.-CHAIN, DIMER

Technical Codes

VGL101

VGL-101

External Clinical & Regulatory Resources

Previous UNII23Q58CY54R

Next UNII23Q86Z38EX